Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

512 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

A Study of Oral LGH447 in Patients With Relapsed and/or Refractory Multiple Myeloma

NCT01456689

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Novartis Investigative Site Chicago, Illinois, United States

Novartis Investigative Site Ann Arbor, Michigan, United States

Novartis Investigative Site Rochester, Minnesota, United States

Novartis Investigative Site Houston, Texas, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT00612716

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant

NCT01426828

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

University of Texas, MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma

NCT02504359

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Duke University Medical Center Durham, North Carolina, United States

OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

NCT00469209

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

NCT00534118

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +58 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

NCT00084747

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT

NCT01885897

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +28 more
Locations: Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States

Washington University St Louis, Missouri, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter

NCT00006083

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +94 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer

NCT00070382

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +55 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions